Pharmatec Engineering ApS: Financial statements 2024
CVR: 37819859
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Pharmatec Engineering ApS (CVR 37819859) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 949,238 and a net result of DKK 323,508 compared with DKK 604,813 the year before. That is a decrease of 44.3% compared with the year before. Equity in the 2024 report amounted to DKK 1,884,798. The solvency ratio was 84%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 949,238
- Profit/Loss
- DKK 323,508
- Equity
- DKK 1,884,798
- Total Assets
- DKK 2,242,657
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 949 t. | 324 t. | 1.9 mio. | 1 |
| 2023 | - | 1.7 mio. | 605 t. | 1.7 mio. | 1 |
| 2022 | - | 1.3 mio. | 258 t. | 1.2 mio. | 1 |
| 2021 | - | 997 t. | 306 t. | 1.1 mio. | 1 |
| 2020 | - | 840 t. | 309 t. | 793 t. | 1 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Pharmatec Engineering ApS has published its annual report for 2023. Gross profit came to DKK 1,703,818, and the net result was DKK 604,813.
About Pharmatec Engineering ApS
Pharmatec Engineering ApS is a Danish company of the type Anpartsselskab based in Roskilde, founded in 2016. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The management consists of Kim Fasting. The company is owned by Kim Fasting. The company has 1 employee (2018). In 2025, the company reported a gross profit of DKK 1,380,062 and a net result of DKK 2,278,538 compared with DKK 323,508 the year before. Equity in the 2025 report amounted to DKK 4,028,336.